{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:29:05Z","timestamp":1791862145597,"version":"4.3.4"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA249185"],"award-info":[{"award-number":["R01CA249185"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["X01HD100702"],"award-info":[{"award-number":["X01HD100702"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008258","name":"Hyundai Motor Group | Hyundai Motor America | Hyundai Hope On Wheels","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008258","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-65134-y","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:47:45Z","timestamp":1763729265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6633-1468","authenticated-orcid":false,"given":"Caroline R. M.","family":"Wiggers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene Y.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6825-6305","authenticated-orcid":false,"given":"Merve","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbolahan","family":"Bamgbose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7091-8578","authenticated-orcid":false,"given":"Justin","family":"Hegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Frede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederike","family":"Warlitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8384-6217","authenticated-orcid":false,"given":"Tayla B.","family":"Heavican-Foral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan","family":"Shraim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6128-9985","authenticated-orcid":false,"given":"Petri","family":"P\u00f6l\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thai Hoa","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1850","authenticated-orcid":false,"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7373-8987","authenticated-orcid":false,"given":"David T.","family":"Teachey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2387-5462","authenticated-orcid":false,"given":"Jacob R.","family":"Bledsoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5336-0216","authenticated-orcid":false,"given":"Yana","family":"Pikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9956-664X","authenticated-orcid":false,"given":"Marian H.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Place","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis B.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-2445","authenticated-orcid":false,"given":"Jens G.","family":"Lohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8040-0535","authenticated-orcid":false,"given":"Birgit","family":"Knoechel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"65134_CR1","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan, M., Hopkins, A. & Jaffee, E. M. Tumor mutational burden and response rate to PD-1 inhibition. N. Engl. J. Med. 377, 2500\u20132501 (2017).","journal-title":"N. Engl. J. Med."},{"key":"65134_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41591-022-01754-x","volume":"28","author":"ES Kim","year":"2022","unstructured":"Kim, E. S. et al. Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial. Nat. Med. 28, 939\u2013945 (2022).","journal-title":"Nat. Med."},{"key":"65134_CR3","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","volume":"351","author":"N McGranahan","year":"2016","unstructured":"McGranahan, N. et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science 351, 1463\u20131469 (2016).","journal-title":"Science"},{"key":"65134_CR4","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","volume":"21","author":"A Marabelle","year":"2020","unstructured":"Marabelle, A. et al. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Lancet Oncol. 21, 1353\u20131365 (2020).","journal-title":"Lancet Oncol."},{"key":"65134_CR5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ccell.2020.04.015","volume":"37","author":"MT Witkowski","year":"2020","unstructured":"Witkowski, M. T. et al. Extensive remodeling of the immune microenvironment in B cell acute lymphoblastic leukemia. Cancer Cell 37, 867\u2013882.e12 (2020).","journal-title":"Cancer Cell"},{"key":"65134_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/cas.15186","volume":"113","author":"T Mikami","year":"2022","unstructured":"Mikami, T. et al. Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia. Cancer Sci. 113, 41\u201352 (2022).","journal-title":"Cancer Sci."},{"key":"65134_CR7","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1172\/JCI137181","volume":"130","author":"RL Terry","year":"2020","unstructured":"Terry, R. L. et al. Immune profiling of pediatric solid tumors. J. Clin. Investig. 130, 3391\u20133402 (2020).","journal-title":"J. Clin. Investig."},{"key":"65134_CR8","doi-asserted-by":"crossref","unstructured":"Wang, X. et al. Single-Cell RNA-seq of T cells in B-ALL patients reveals an exhausted subset with remarkable heterogeneity. Adv. Sci. 8, e2101447 (2021).","DOI":"10.1002\/advs.202101447"},{"key":"65134_CR9","doi-asserted-by":"crossref","unstructured":"Lasry, A. et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat Cancer. 4, 27\u201342 (2022).","DOI":"10.1038\/s43018-022-00480-0"},{"key":"65134_CR10","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng, C. et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell 169, 1342\u2013-1356.e16 (2017).","journal-title":"Cell"},{"key":"65134_CR11","first-page":"374","volume":"1979","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 1979, 374 (2021).","journal-title":"Science"},{"key":"65134_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.omtn.2023.03.007","volume":"32","author":"X Jin","year":"2023","unstructured":"Jin, X. et al. Identification of shared characteristics in tumor-infiltrating T cells across 15 cancers. Mol. Ther. Nucleic Acids 32, 189\u2013202 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"65134_CR13","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","volume":"54","author":"SW Brady","year":"2022","unstructured":"Brady, S. W. et al. The genomic landscape of pediatric acute lymphoblastic leukemia. Nat. Genet. 54, 1376\u20131389 (2022).","journal-title":"Nat. Genet."},{"key":"65134_CR14","doi-asserted-by":"publisher","first-page":"a035246","DOI":"10.1101\/cshperspect.a035246","volume":"10","author":"F Gianni","year":"2020","unstructured":"Gianni, F., Belver, L. & Ferrando, A. The genetics and mechanisms of T-cell acute lymphoblastic leukemia. Cold Spring Harb. Perspect. Med 10, a035246 (2020).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"65134_CR15","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat. Genet 49, 1211\u20131218 (2017).","journal-title":"Nat. Genet"},{"key":"65134_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39152-z","volume":"13","author":"SS Bhasin","year":"2023","unstructured":"Bhasin, S. S. et al. Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis. Sci. Rep. 13, 12556 (2023).","journal-title":"Sci. Rep."},{"key":"65134_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64929-x","volume":"10","author":"M Caron","year":"2020","unstructured":"Caron, M. et al. Single-cell analysis of childhood leukemia reveals a link between developmental states and ribosomal protein expression as a source of intra-individual heterogeneity. Sci. Rep. 10, 8079 (2020).","journal-title":"Sci. Rep."},{"key":"65134_CR18","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1200\/JCO.21.02678","volume":"40","author":"DT Teachey","year":"2022","unstructured":"Teachey, D. T. et al. Children\u2019s Oncology Group Trial AALL1231: a phase III clinical trial testing bortezomib in newly diagnosed T-cell acute lymphoblastic leukemia and lymphoma. J. Clin. Oncol. 40, 2106\u20132118 (2022).","journal-title":"J. Clin. Oncol."},{"key":"65134_CR19","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1182\/blood.2023020678","volume":"142","author":"B Wood","year":"2023","unstructured":"Wood, B. et al. Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children\u2019s Oncology Group Study. Blood J. 142, 2069\u20132078 (2023).","journal-title":"Blood J."},{"key":"65134_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/ng.2913","volume":"46","author":"B Knoechel","year":"2014","unstructured":"Knoechel, B. et al. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia. Nat. Genet. 46, 364\u2013370 (2014).","journal-title":"Nat. Genet."},{"key":"65134_CR21","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1636","volume":"13","author":"T Palomero","year":"2007","unstructured":"Palomero, T. et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat. Med. 13, 1203\u20131210 (2007).","journal-title":"Nat. Med."},{"key":"65134_CR22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3324\/haematol.2019.217687","volume":"105","author":"V Agnusdei","year":"2020","unstructured":"Agnusdei, V. et al. Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts. Haematologica 105, 1317\u20131328 (2020).","journal-title":"Haematologica"},{"key":"65134_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40164-022-00368-w","volume":"12","author":"D Caracciolo","year":"2023","unstructured":"Caracciolo, D. et al. The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives. Exp. Hematol. Oncol. 12, 5 (2023).","journal-title":"Exp. Hematol. Oncol."},{"key":"65134_CR24","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u2013-3587.e29 (2021).","journal-title":"Cell"},{"key":"65134_CR25","doi-asserted-by":"publisher","unstructured":"Dann, E., Henderson, N. C., Teichmann, S. A., Morgan, M. D., and Marioni, J. C. Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-021-01033-z.(2021).","DOI":"10.1038\/s41587-021-01033-z"},{"key":"65134_CR26","doi-asserted-by":"publisher","first-page":"108684","DOI":"10.1016\/j.celrep.2020.108684","volume":"34","author":"HJ Sutton","year":"2021","unstructured":"Sutton, H. J. et al. Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans. Cell Rep. 34, 108684 (2021).","journal-title":"Cell Rep."},{"key":"65134_CR27","doi-asserted-by":"publisher","first-page":"102227","DOI":"10.1016\/j.coi.2022.102227","volume":"77","author":"AA Ambegaonkar","year":"2022","unstructured":"Ambegaonkar, A. A., Holla, P., Dizon, B. L., Sohn, H. & Pierce, S. K. Atypical B cells in chronic infectious diseases and systemic autoimmunity: puzzles with many missing pieces. Curr. Opin. Immunol. 77, 102227 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"65134_CR28","doi-asserted-by":"publisher","first-page":"440","DOI":"10.4049\/jimmunol.181.1.440","volume":"181","author":"A Bristeau-Leprince","year":"2008","unstructured":"Bristeau-Leprince, A. et al. Human TCR \u03b1\/\u03b2\u2009+\u2009CD4\u2009\u2212\u2009CD8\u2212 double-negative T cells in patients with autoimmune lymphoproliferative syndrome express restricted V\u03b2 TCR diversity and are clonally related to CD8\u2009+\u2009T cells.  J. Immunol. 181, 440\u2013448 (2008).","journal-title":"J. Immunol."},{"key":"65134_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1158\/1078-0432.CCR-13-0945","volume":"20","author":"Q Ye","year":"2014","unstructured":"Ye, Q. et al. CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor. Clin. Cancer Res. 20, 44\u201355 (2014).","journal-title":"Clin. Cancer Res."},{"key":"65134_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23324-4","volume":"12","author":"M Andreatta","year":"2021","unstructured":"Andreatta, M. et al. Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat. Commun. 12, 2965 (2021).","journal-title":"Nat. Commun."},{"key":"65134_CR31","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"65134_CR32","doi-asserted-by":"publisher","first-page":"eaah4573","DOI":"10.1126\/science.aah4573","volume":"356","author":"A-C Villani","year":"2017","unstructured":"Villani, A.-C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356, eaah4573 (2017).","journal-title":"Science"},{"key":"65134_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","volume":"33","author":"J Cros","year":"2010","unstructured":"Cros, J. et al. Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors. Immunity 33, 375\u2013386 (2010).","journal-title":"Immunity"},{"key":"65134_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-10-403","volume":"10","author":"P Ancuta","year":"2009","unstructured":"Ancuta, P. et al. Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets. BMC Genomics 10, 403 (2009).","journal-title":"BMC Genomics"},{"key":"65134_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18873-z","volume":"11","author":"R Hou","year":"2020","unstructured":"Hou, R., Denisenko, E., Ong, H. T., Ramilowski, J. A. & Forrest, A. R. R. Predicting cell-to-cell communication networks using NATMI. Nat. Commun. 11, 5011 (2020).","journal-title":"Nat. Commun."},{"key":"65134_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","volume":"17","author":"R Browaeys","year":"2020","unstructured":"Browaeys, R., Saelens, W. & Saeys, Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat. Methods 17, 159\u2013162 (2020).","journal-title":"Nat. Methods"},{"key":"65134_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbrc.2007.04.100","volume":"358","author":"A Schulte","year":"2007","unstructured":"Schulte, A. et al. Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by \u03b1- and \u03b3-secretases. Biochem. Biophys. Res. Commun. 358, 233\u2013240 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"65134_CR38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bbrc.2008.03.088","volume":"370","author":"A Schramme","year":"2008","unstructured":"Schramme, A., Abdel-Bakky, M. S., K\u00e4mpfer-Kolb, N., Pfeilschifter, J. & Gutwein, P. The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells. Biochem Biophys. Res. Commun. 370, 311\u2013316 (2008).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"65134_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nprot.2014.006","volume":"9","author":"S Picelli","year":"2014","unstructured":"Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171\u2013181 (2014).","journal-title":"Nat. Protoc."},{"key":"65134_CR40","doi-asserted-by":"publisher","unstructured":"Wange, R. L. LAT, the Linker for activation of T cells: a bridge between T cell-specific and general signaling pathways. Science\u2019s STKE 2000 https:\/\/doi.org\/10.1126\/stke.2000.63.re1 (2000).","DOI":"10.1126\/stke.2000.63.re1"},{"key":"65134_CR41","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1128\/MCB.22.4.1001-1015.2002","volume":"22","author":"K Katagiri","year":"2002","unstructured":"Katagiri, K., Hattori, M., Minato, N. & Kinashi, T. Rap1 functions as a key regulator of T-cell and antigen-presenting cell interactions and modulates T-cell responses. Mol. Cell Biol. 22, 1001\u20131015 (2002).","journal-title":"Mol. Cell Biol."},{"key":"65134_CR42","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1515\/hsz-2016-0107","volume":"397","author":"J Ryan","year":"2016","unstructured":"Ryan, J., Montero, J., Rocco, J. & Letai, A. iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry. Biol. Chem. 397, 671\u2013678 (2016).","journal-title":"Biol. Chem."},{"key":"65134_CR43","doi-asserted-by":"publisher","first-page":"e1040144","DOI":"10.1080\/23723556.2015.1040144","volume":"3","author":"J Montero","year":"2016","unstructured":"Montero, J. & Letai, A. Dynamic BH3 profiling-poking cancer cells with a stick. Mol. Cell Oncol. 3, e1040144 (2016).","journal-title":"Mol. Cell Oncol."},{"key":"65134_CR44","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1182\/bloodadvances.2021005634","volume":"6","author":"TH Tran","year":"2022","unstructured":"Tran, T. H. et al. Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001. Blood Adv. 6, 1329\u20131341 (2022).","journal-title":"Blood Adv."},{"key":"65134_CR45","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1182\/blood.2023021184","volume":"143","author":"RJ Hayashi","year":"2024","unstructured":"Hayashi, R. J. et al. MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children\u2019s Oncology Group trial AALL1231. Blood 143, 2053\u20132058 (2024).","journal-title":"Blood"},{"key":"65134_CR46","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S. & Schumacher, T. N. T Cell Dysfunction in Cancer. Cancer Cell 33, 547\u2013562 (2018).","journal-title":"Cancer Cell"},{"key":"65134_CR47","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","volume":"176","author":"H Li","year":"2019","unstructured":"Li, H. et al. Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma. Cell 176, 775\u2013789.e18 (2019).","journal-title":"Cell"},{"key":"65134_CR48","doi-asserted-by":"crossref","unstructured":"Itahashi, K. et al. BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors. Sci. Immunol. 7,eabk0957 (2022).","DOI":"10.1126\/sciimmunol.abk0957"},{"key":"65134_CR49","doi-asserted-by":"publisher","first-page":"eadp0004","DOI":"10.1126\/scitranslmed.adp0004","volume":"16","author":"B Kumar","year":"2024","unstructured":"Kumar, B. et al. BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML. Sci. Transl. Med 16, eadp0004 (2024).","journal-title":"Sci. Transl. Med"},{"key":"65134_CR50","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1038\/s41375-022-01676-0","volume":"36","author":"P Jiang","year":"2022","unstructured":"Jiang, P. et al. Single-cell ATAC-seq maps the comprehensive and dynamic chromatin accessibility landscape of CAR-T cell dysfunction. Leukemia 36, 2656\u20132668 (2022).","journal-title":"Leukemia"},{"key":"65134_CR51","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.ccell.2022.09.013","volume":"40","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells. Cancer Cell 40, 1407\u20131422.e7 (2022).","journal-title":"Cancer Cell"},{"key":"65134_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00667-w","volume":"12","author":"S Sui","year":"2024","unstructured":"Sui, S. et al. BRD4 inhibitor reduces exhaustion and blocks terminal differentiation in CAR-T cells by modulating BATF and EGR1. Biomark. Res 12, 124 (2024).","journal-title":"Biomark. Res"},{"key":"65134_CR53","doi-asserted-by":"crossref","unstructured":"Wu, Z. et al. CD3\u2009+\u2009CD4-CD8- (Double-Negative) T cells in inflammation, immune disorders and cancer. Front. Immunol. 13 (2022).","DOI":"10.3389\/fimmu.2022.816005"},{"key":"65134_CR54","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/eji.201040982","volume":"41","author":"S Voelkl","year":"2011","unstructured":"Voelkl, S., Gary, R. & Mackensen, A. Characterization of the immunoregulatory function of human TCR-\u03b1\u03b2\u2009+\u2009CD4\u2009\u2212\u2009CD8\u2212 double-negative T cells. Eur. J. Immunol. 41, 739\u2013748 (2011).","journal-title":"Eur. J. Immunol."},{"key":"65134_CR55","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","volume":"181","author":"JC Crispi\u0301n","year":"2008","unstructured":"Crispi\u0301n, J. C. et al. Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys.  J. Immunol. 181, 8761\u20138766 (2008).","journal-title":"J. Immunol."},{"key":"65134_CR56","doi-asserted-by":"crossref","unstructured":"Maccari, M. E. et al. A distinct CD38\u2009+\u2009CD45RA+ population of CD4\u2009+\u2009, CD8\u2009+\u2009, and double-negative T cells is controlled by FAS. J. Exp. Med. 218 (2021).","DOI":"10.1084\/jem.20192191"},{"key":"65134_CR57","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3324\/haematol.2013.085068","volume":"98","author":"L Couronne","year":"2013","unstructured":"Couronne, L. et al. STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model. Haematologica 98, 1748\u20131752 (2013).","journal-title":"Haematologica"},{"key":"65134_CR58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jcmgh.2019.08.004","volume":"9","author":"D Di Blasi","year":"2020","unstructured":"Di Blasi, D., Boldanova, T., Mori, L., Terracciano, L., Heim, M. H. & De Libero, G. Unique T-cell populations define immune-inflamed hepatocellular carcinoma. Cell Mol. Gastroenterol. Hepatol. 9, 195\u2013218 (2020).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"65134_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-022-00360-w","volume":"10","author":"X Chen","year":"2022","unstructured":"Chen, X., Wang, D. & Zhu, X. Application of double-negative T cells in haematological malignancies: recent progress and future directions. Biomark. Res. 10, 11 (2022).","journal-title":"Biomark. Res."},{"key":"65134_CR60","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/imm.13441","volume":"165","author":"T Velikkakam","year":"2022","unstructured":"Velikkakam, T., Gollob, K. J. & Dutra, W. O. Double-negative T cells: Setting the stage for disease control or progression. Immunology 165, 371\u2013385 (2022).","journal-title":"Immunology"},{"key":"65134_CR61","doi-asserted-by":"publisher","unstructured":"Anderson, N. D. et al. Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-023-02415-3. (2023).","DOI":"10.1038\/s41591-023-02415-3"},{"key":"65134_CR62","doi-asserted-by":"crossref","unstructured":"Le Gallou, S. et al. Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma. Front Immunol 12. .(2021).","DOI":"10.3389\/fimmu.2021.755623"},{"key":"65134_CR63","first-page":"4512","volume":"184","author":"M Di Pilato","year":"2021","unstructured":"Di Pilato, M. et al. CXCR6 positions cytotoxic T. cells Receiv. Crit. Survival Signals Tumor Microenviron. Cell 184, 4512\u20134530.e22 (2021).","journal-title":"cells Receiv. Crit. Survival Signals Tumor Microenviron. Cell"},{"key":"65134_CR64","doi-asserted-by":"crossref","unstructured":"Lee, J. S. et al. Statins enhance efficacy of venetoclax in blood cancers. Sci. Transl. Med. 10 (2018).","DOI":"10.1126\/scitranslmed.aaq1240"},{"key":"65134_CR65","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13046-022-02421-2","volume":"41","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Expanding anti-CD38 immunotherapy for lymphoid malignancies. J. Exp. Clin. Cancer Res. 41, 210 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"65134_CR66","doi-asserted-by":"crossref","unstructured":"Morandi, F. et al. CD38: a target for immunotherapeutic approaches in multiple myeloma. Front. Immunol. 9 (2018).","DOI":"10.3389\/fimmu.2018.02722"},{"key":"65134_CR67","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1084\/jem.20190186","volume":"216","author":"F Vences-Catal\u00e1n","year":"2019","unstructured":"Vences-Catal\u00e1n, F. et al. CD81 is a novel immunotherapeutic target for B cell lymphoma. J. Exp. Med. 216, 1497\u20131508 (2019).","journal-title":"J. Exp. Med."},{"key":"65134_CR68","doi-asserted-by":"crossref","unstructured":"Vences-Catal\u00e1n, F. et al. Targeting the tetraspanin CD81 reduces cancer invasion and metastasis. Proceedings of the National Academy of Sciences 118 (2021).","DOI":"10.1073\/pnas.2018961118"},{"key":"65134_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01800-3","volume":"22","author":"X Chu","year":"2023","unstructured":"Chu, X., Tian, W., Wang, Z., Zhang, J. & Zhou, R. Co-inhibition of TIGIT and PD-1\/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials. Mol. Cancer 22, 93 (2023).","journal-title":"Mol. Cancer"},{"key":"65134_CR70","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1001\/jamaoncol.2023.3867","volume":"9","author":"TW Kim","year":"2023","unstructured":"Kim, T. W. et al. Anti-TIGIT antibody tiragolumab alone or with atezolizumab in patients with advanced solid tumors. JAMA Oncol. 9, 1574 (2023).","journal-title":"JAMA Oncol."},{"key":"65134_CR71","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-023-01499-1","volume":"16","author":"L Cai","year":"2023","unstructured":"Cai, L., Li, Y., Tan, J., Xu, L. & Li, Y. Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy. J. Hematol. Oncol. 16, 101 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"65134_CR72","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.ccell.2023.09.001","volume":"41","author":"I Ausejo-Mauleon","year":"2023","unstructured":"Ausejo-Mauleon, I. et al. TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory. Cancer Cell 41, 1911\u20131926.e8 (2023).","journal-title":"Cancer Cell"},{"key":"65134_CR73","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jmoldx.2016.02.003","volume":"18","author":"MJ Kluk","year":"2016","unstructured":"Kluk, M. J. et al. Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.  J. Mol. Diagnostics 18, 507\u2013515 (2016).","journal-title":"J. Mol. Diagnostics"},{"key":"65134_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1603-1","volume":"19","author":"M Stoeckius","year":"2018","unstructured":"Stoeckius, M. et al. Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol. 19, 224 (2018).","journal-title":"Genome Biol."},{"key":"65134_CR75","doi-asserted-by":"publisher","first-page":"W739","DOI":"10.1093\/nar\/gkac382","volume":"50","author":"A Ianevski","year":"2022","unstructured":"Ianevski, A., Giri, A. K. & Aittokallio, T. SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. Nucleic Acids Res. 50, W739\u2013W743 (2022).","journal-title":"Nucleic Acids Res."},{"key":"65134_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GXY Zheng","year":"2017","unstructured":"Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"65134_CR77","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281\u2013291.e9 (2019).","journal-title":"Cell Syst."},{"key":"65134_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02547-0","volume":"22","author":"W Muskovic","year":"2021","unstructured":"Muskovic, W. & Powell, J. E. DropletQC: improved identification of empty droplets and damaged cells in single-cell RNA-seq data. Genome Biol. 22, 329 (2021).","journal-title":"Genome Biol."},{"key":"65134_CR79","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"65134_CR80","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865\u2013868 (2017).","journal-title":"Nat. Methods"},{"key":"65134_CR81","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive Integration of Single-Cell Data. Cell 177, 1888\u20131902.e21 (2019).","journal-title":"Cell"},{"key":"65134_CR82","unstructured":"Nazarov, V. I. et al. immunarch: Bioinformatics Analysis of T-Cell and B-Cell Immune Repertoires. (2022)."},{"key":"65134_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40966-8","volume":"14","author":"DG Coffey","year":"2023","unstructured":"Coffey, D. G. et al. Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma. Nat. Commun. 14, 5335 (2023).","journal-title":"Nat. Commun."},{"key":"65134_CR84","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41587-021-00989-2","volume":"40","author":"SA Schattgen","year":"2022","unstructured":"Schattgen, S. A. et al. Integrating T cell receptor sequences and transcriptional profiles by clonotype neighbor graph analysis (CoNGA. Nat. Biotechnol. 40, 54\u201363 (2022).","journal-title":"Nat. Biotechnol."},{"key":"65134_CR85","unstructured":"Tickle, T., Tirosh, I., Georgescu, C., Brown, M. & Haas, B. inferCNV of the Trinity CTAT Project. https:\/\/github.com\/broadinstitute\/inferCNV.(2019)."},{"key":"65134_CR86","doi-asserted-by":"crossref","unstructured":"Gueguen, P. et al.Contribution of resident and circulating precursors to tumor-infiltrating CD8\u2009+\u2009T cell populations in lung cancer. Sci. Immunol. 6 (2021).","DOI":"10.1126\/sciimmunol.abd5778"},{"key":"65134_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"65134_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25771-5","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients. Nat. Commun. 12, 5444 (2021).","journal-title":"Nat. Commun."},{"key":"65134_CR89","doi-asserted-by":"publisher","first-page":"960918","DOI":"10.3389\/fimmu.2022.960918","volume":"13","author":"J Roels","year":"2022","unstructured":"Roels, J. et al. Transcriptional dynamics and epigenetic regulation of E and ID protein encoding genes during human T cell development. Front Immunol. 13, 960918 (2022).","journal-title":"Front Immunol."},{"key":"65134_CR90","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41590-020-0747-9","volume":"21","author":"J Roels","year":"2020","unstructured":"Roels, J. et al. Distinct and temporary-restricted epigenetic mechanisms regulate human \u03b1\u03b2 and \u03b3\u03b4 T cell development. Nat. Immunol. 21, 1280\u20131292 (2020).","journal-title":"Nat. Immunol."},{"key":"65134_CR91","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","volume":"26","author":"G Monaco","year":"2019","unstructured":"Monaco, G. et al. RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types. Cell Rep. 26, 1627\u20131640.e7 (2019).","journal-title":"Cell Rep."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65134-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65134-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65134-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:04:28Z","timestamp":1763733868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65134-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65134"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65134-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.G.L. received research funding from Bristol Myers Squibb for an unrelated project. D.T.T. serves on advisory boards for AbbVie, Amgen, BEAM Therapeutics, Jazz, J&J Innovation (Janssen), Novartis, Pfizer, Sobi, Servier and Syndax without direct compensation. D.T.T receives research funding from BEAM Therapeutics and NeoImmune Tech. D.T.T. has patents or patents pending on CAR-T. C.G.M. reports research support from Pfizer and AbbVie; received honoraria from Amgen and Illumina; and reports equity in Amgen. The remaining authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10263"}}